{"id":"placebo-for-prednisolon","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL521875","moleculeType":"Small molecule","molecularWeight":"460.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used as controls in clinical trials to establish the efficacy of an active drug by comparison. Any observed effects in placebo groups are attributed to the placebo effect—psychological and physiological responses driven by patient expectation rather than pharmacological action. In this Phase 3 trial context, the placebo serves as the control arm against which prednisolone efficacy is measured.","oneSentence":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:18.537Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 clinical trial comparing prednisolone efficacy"}]},"trialDetails":[{"nctId":"NCT05638633","phase":"PHASE3","title":"Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome","status":"COMPLETED","sponsor":"Wuerzburg University Hospital","startDate":"2022-11-11","conditions":"Post-COVID-19 Syndrome","enrollment":321},{"nctId":"NCT04315350","phase":"NA","title":"The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance","status":"TERMINATED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2019-12-01","conditions":"Insulin Resistance, Non-Alcoholic Fatty Liver Disease","enrollment":24},{"nctId":"NCT02000336","phase":"PHASE3","title":"Comparison of the Effectiveness of Two Different Dosages of Cortisone Compared to Placebo in Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Prof. Dr. rer. nat. H.J. Trampisch","startDate":"2014-01","conditions":"Progression of Rheumatoid Arthritis","enrollment":395},{"nctId":"NCT02935101","phase":"PHASE2","title":"Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants","status":"TERMINATED","sponsor":"Prof. Dominique de Quervain, MD","startDate":"2016-10","conditions":"Opioid Dependence, Cocaine Dependence","enrollment":4},{"nctId":"NCT01275638","phase":"PHASE4","title":"The Effect of Moderate-Dose Steroid Therapy in Sepsis","status":"COMPLETED","sponsor":"TC Erciyes University","startDate":"2005-04","conditions":"Sepsis","enrollment":55}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["N.I."],"phase":"phase_3","status":"active","brandName":"Placebo for Prednisolon","genericName":"Placebo for Prednisolon","companyName":"Wuerzburg University Hospital","companyId":"wuerzburg-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in Phase 3 clinical trial comparing prednisolone efficacy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}